Skip to content

Applied Research pseudocyst endoscopic treatment of a variety of minimally invasive techniques in severe acute pancreatitis with pancreatic

Variety of minimally invasive endoscopic techniques in severe acute pancreatitis treatment of pancreatic pseudocysts prospective applications, parallel, non-randomized treatment study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-14004986
Enrollment
Unknown
Registered
2014-07-16
Start date
2014-07-21
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe acute pancreatitis with pancreatic pseudocyst

Interventions

Transmural drainage of the stomach and duodenum+Pa:Transmural drainage of the stomach and duodenum
Percutaneous drainage+Pancreatic stent drainage:Percutaneous drainage

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: a) aged 18 to 70 years old; b) four weeks after the onset of acute pancreatitis; c) the definition of pseudocyst by 2012 revised classification criteria Atlanta, namely enhanced CT or EUS showed homogeneous low density area around the cyst fluid accumulation was significantly enhanced, excluding non-liquid ingredients; d) the following symptoms or complications: oppression large vessels; oppression of the stomach or duodenum cause bloating, nausea, vomiting, pain and other symptoms; oppression caused by the common bile duct stenosis or cholestasis; infection or bleeding; gastrointestinal bleeding; chest pancreatic fistula; cyst larger than 4cm, formed more than six weeks of its shape and size unchanged or larger; cyst formation time of more than six weeks, may cause complications.

Exclusion criteria

Exclusion criteria: a) the incidence of acute pancreatitis in 4 weeks; b) no symptoms and complications, cysts less than 4cm formed and who formed less than six weeks; c) severe heart,lung, liver disease, coagulation disorders,and there are other endoscopic contraindications; d) pregnant or lactating women; e) refused to sign an informed consent.

Design outcomes

Secondary

MeasureTime frame
The complication rate;Operation rate;Mortality rate;

Primary

MeasureTime frame
The success rate of intervention;Cyst recurrence rate;

Countries

China

Contacts

Public ContactLiang Xia
liangx96180@126.com+86 13870871395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026